140 related articles for article (PubMed ID: 21778744)
1. Bisphosphonate therapy in children with secondary osteoporosis.
Papapoulos SE
Horm Res Paediatr; 2011; 76 Suppl 1():24-7. PubMed ID: 21778744
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions.
Szalay EA
J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in children and young adults.
Sakka SD
Best Pract Res Clin Rheumatol; 2022 Sep; 36(3):101776. PubMed ID: 36109301
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of bisphosphonate.].
Nakamura M; Koide M; Udagawa N
Clin Calcium; 2016; 26(11):1561-1570. PubMed ID: 27777389
[TBL] [Abstract][Full Text] [Related]
5. Who will benefit from antiresorptive treatment (bisphosphonates)?
Papapoulos SE
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190
[TBL] [Abstract][Full Text] [Related]
6. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate therapy for secondary osteoporosis: adult perspective.
Reid IR
Horm Res Paediatr; 2011; 76 Suppl 1():28-32. PubMed ID: 21778745
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis.
Brumsen C; Hamdy NA; Papapoulos SE
Medicine (Baltimore); 1997 Jul; 76(4):266-83. PubMed ID: 9279333
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of bisphosphonates in osteoporosis.
Watts NB; Diab DL
J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
[TBL] [Abstract][Full Text] [Related]
10. Use of bisphosphonates in the management of postmenopausal osteoporosis.
Papapoulos SE
Ann N Y Acad Sci; 2011 Feb; 1218():15-32. PubMed ID: 20946579
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate use in patients undergoing dialysis.
Vouri SM; Blaszczyk AT
Consult Pharm; 2013 Nov; 28(11):738-41. PubMed ID: 24217193
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
Ito K; Blinder VS; Elkin EB
J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
[TBL] [Abstract][Full Text] [Related]
13. [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].
Semler O; Land C; Schönau E
Orthopade; 2007 Feb; 36(2):146-51. PubMed ID: 17252257
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE
Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613
[TBL] [Abstract][Full Text] [Related]
15. When to use bisphosphonates.
Bachrach LK; Gandrud LM
J Pediatr; 2004 Feb; 144(2):285; author reply 285-6. PubMed ID: 14760281
[No Abstract] [Full Text] [Related]
16. Bisphosphonates for prevention of postmenopausal osteoporosis.
Ravn P
Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for osteoporosis--where do we go from here?
Whitaker M; Guo J; Kehoe T; Benson G
N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
[No Abstract] [Full Text] [Related]
18. Is there a role for bisphosphonates in chronic kidney disease?
Miller PD
Semin Dial; 2007; 20(3):186-90. PubMed ID: 17555478
[TBL] [Abstract][Full Text] [Related]
19. Bone mass homeostasis and bisphosphonate action.
Rodan GA
Bone; 1997 Jan; 20(1):1-4. PubMed ID: 8988341
[TBL] [Abstract][Full Text] [Related]
20. Use of bisphosphonates in the prevention of bone loss and fractures.
Parfitt AM
Am J Med; 1991 Nov; 91(5B):42S-46S. PubMed ID: 1750416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
